Sanner achieves over EUR 85 million sales record

Optimistic outlook despite Corona crisis

70
Sanner
With Sanner BioBase, the company launched the first

Germany-based Sanner, an international manufacturer of pharmaceutical primary packaging and medical technology products, has completed a successful business year 2019, with a total turnover of just over EUR 85 million (approximately Rs 720 crore), company mentioned this in a press statement.

Due to investments in new products and existing sites, Sanner is optimistic about the future despite the Corona crisis. With a group turnover of more than EUR 85 million (approximately Rs 720 crore), Sanner has set a new company record. The development in Europe was stable; slight increases were achieved in China. The company recorded an above-average growth of 25% in the US and even more than 30% in India.

According to the company, the demand is particularly strong for products from the “Engineered Product Solutions” segment. Sanner offers diagnostic solutions such as rapid tests and pulmonary applications such as inhalers and customized primary packaging.

“We will continue to expand our business in the coming years. This includes innovations in the existing Sanner product portfolio as well as investments in internal developments,” says Johannis Willem van Vliet, managing director of the Sanner Group. “We are already successfully working on integrating electronics into injection molded parts. A further focus is on smart packaging and medical device development. We are thus expanding our competence and strengthening our value proposition – high volumes in plastics processing at the highest quality.”

New products and market segments

At the beginning of this year, the company launched Sanner BioBase, the first effervescent tablet packaging made of bio-based material. The tablet tube is recyclable and increases resource efficiency. Higher H20 barrier properties extend the tablets’ shelf life, an essential argument for customers and consumers. In terms of handling, Sanner BioBase offers consumers a high-quality feel and appearance. The tube can be printed or provided with an IML label.

With its range of medical cannabis packaging, the company serves another market segment – and has already developed a first solution with the child-resistant tablet and capsule container TabTec CR. It features Sanner’s patented ‘Press and Flip’ opening mechanism, making it difficult for children to open, but easy for adults to open and reclose. The integrated pouring opening allows individual capsules or tablets to be removed easily and hygienically. Due to its slim shape, the container fits in any shirt or trouser pocket, while the innovative design stands out from other products at the point of sale.

Positive outlook despite Corona crisis

At Sanner, work continues despite the Covid-19 pandemic. The company has even increased its production capacity in Bensheim, Germany, to meet the increased demand, such as for effervescent tablet packaging and medical devices such as inhalers or parts for rapid tests. Three new machines for the production of desiccant closures were already put into operation for this purpose. In China, the plant was ramped up again at the end of February after several weeks of closure and is now running at full speed, with the construction of the second production plant in concrete planning.

Sanner is also continuing to invest in the Bensheim headquarters’ infrastructure, for example, by implementing a new manufacturing execution system. “We expect an increased demand for our products in Europe, the US and Asia – despite or even because of the Corona crisis,” says van Vliet. “Accordingly, we are expecting sales to grow further this year.”

The Covid-19 pandemic led to the country-wide lockdown on 25 March 2020. It will be two years tomorrow as I write this. What have we learned in this time? Maybe the meaning of resilience since small companies like us have had to rely on our resources and the forbearance of our employees as we have struggled to produce our trade platforms.

The print and packaging industries have been fortunate, although the commercial printing industry is still to recover. We have learned more about the digital transformation that affects commercial printing and packaging. Ultimately digital will help print grow in a country where we are still far behind in our paper and print consumption and where digital is a leapfrog technology that will only increase the demand for print in the foreseeable future.

Web analytics show that we now have readership in North America and Europe amongst the 90 countries where our five platforms reach. Our traffic which more than doubled in 2020, has at times gone up by another 50% in 2021. And advertising which had fallen to pieces in 2020 and 2021, has started its return since January 2022.

As the economy approaches real growth with unevenness and shortages a given, we are looking forward to the PrintPack India exhibition in Greater Noida. We are again appointed to produce the Show Daily on all five days of the show from 26 to 30 May 2022.

It is the right time to support our high-impact reporting and authoritative and technical information with some of the best correspondents in the industry. Readers can power Packaging South Asia’s balanced industry journalism and help sustain us by subscribing.

– Naresh Khanna

Subscribe Now

LEAVE A REPLY

Please enter your comment!
Please enter your name here